GO
Loading...

Former SAC Fund Manager Has Bail Set at $5 Million

Former hedge fund portfolio manager Mathew Martoma will have to put up $5 million bail to remain free on insider trading charges.

Roy Hsu | Getty Images

Federal regulators says the insider trading scheme netted $276 million for Martoma's former firm, CR Intrinsic, a unit of SAC Capital.

The 38-year old former fund manager appeared in federal court with his wife at his side, six days after his arrest in Florida on securities fraud and conspiracy charges.

Prosecutors allege that Martoma obtained inside information on a pivotal Alzheimer's drug trial for a treatment under development by Elan and Wyeth Phramaceuticals . (Wyeth is now owned by Pfizer.)


Martoma's $5 million bond must be secured by three signatories, and $2 million in cash or property. He has surrendered his passport and will be restricted to travel to in New York, New Jersey and to his homes in Florida and Massachusetts.

He is scheduled to be back in court for a preliminary hearing December 26th, if he is not formally indicted by a grand jury first.

-By Bertha Coombs
@coombscnbc

Featured

  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video